In particular, GNE-0723, a novel positive allosteric modulator of GluN2A-containing NMDAR, was shown to ameliorate the cognitive deficits in a mouse model of AD (J20) [195], supporting the importance of the involvement of synaptic NMDAR neurotransmission in AD pathogenesis. The gene discussed is GRIN2A; the disease is Alzheimer disease.